Global Wellness Strategies Inc.
GWSFF
Other OTC0.12
USD
+0.04
- -
Return %
Stock
S&P500
1Y
-44.41
26.53
3Y
142.97
76.60
5Y
-92.17
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Meris Kott
- Sector
- Financial Services
- Industry
- Financial - Credit Services
- Address
- 702 – 595 Howe Street Vancouver BC Canada V6C 2E5
- IPO Date
- Aug 27, 2018
- Website
- globalwellnessstrategies.com
- Similar Companies
- Business
- Global Wellness Strategies Inc. (CSE:LOAN, OTCQB:GWSFF) operates as a merchant bank and prospect generator focused on financing high-growth companies in the wellness, biotechnology, and medical cannabis sectors; it provides debt financing facilities, operational support, management assistance, and access to capital markets without immediate equity dilution. The company offers fixed two-year term loans at 14% compounded monthly interest rates to revenue-generating firms exceeding $2 million annually or with established sales pipelines, secured by collateral valued two to three times the loan amount, alongside options for loan conversion at a 10% discount and rights of first refusal on future financing. Core services encompass incubation and acceleration for biotechnology research targeting pain, depression, mental illness through micro-dosing of organic compounds and synthetic molecules; a beverage division featuring flavored hemp seed products, hemp-infused teas, and hemp-based protein powders; and strategic alliances including First Euro Cannabis for European cannabis debt financing, partnerships with Cannabis Mercantile Exchange for B2B auction platforms, and Fantasy Network Ltd. for Israeli medical cannabis opportunities. Founded as Redfund Capital Corp. and rebranded to Global Wellness Strategies Inc., the company, headquartered in Canada, maintains a nine-step screening process to de-risk investments and holds rights to acquire up to 51% of partners like Wahupta Ventures Inc. for hemp production scaling. Recent activities emphasize scalability in commercialization-stage biotechnology and wellness consumer products, with over 100 years of combined team expertise in capital markets, corporate finance, and healthcare, though no major acquisitions, funding rounds, or new launches have been publicly reported in 2024 or 2025.
XTACY Therapeutics Announces Debt Settlement